Brief: Spago Nanomedical Pauses Recruitment For Clinical Study In Uppsala
April 16 (Reuters) - Spago Nanomedical AB (publ) SPAGO.TE :
* RECRUITMENT FOR CLINICAL STUDY IN UPPSALA, SWEDEN PAUSED
* PATIENT RECRUITMENT FOR CLINICAL STUDY OF SPAGOPIX-01 AT
AKADEMISKA SJUKHUSET IN UPPSALA, SWEDEN TEMPORARILY SUSPENDED
AFTER RE-PRIORITIZATION AS RESULT OF COVID-19
Source text for Eikon: ID:nWkr9GKwJN
Further company coverage: SPAGO.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose